Viewing Study NCT01322295


Ignite Creation Date: 2025-12-24 @ 1:53 PM
Ignite Modification Date: 2025-12-27 @ 9:57 PM
Study NCT ID: NCT01322295
Status: COMPLETED
Last Update Posted: 2017-09-21
First Post: 2011-03-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Human Bronchial Microdialysis in Open Aortic Aneurysm Repair
Sponsor: Norwegian University of Science and Technology
Organization:

Study Overview

Official Title: Human Bronchial Microdialysis in Open Aortic Aneurysm Repair
Status: COMPLETED
Status Verified Date: 2017-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Elective open aortic aneurysm repair has an overall reported 30 day mortality of 2-6 percent, but in patients more than 65-70 years the mortality is reported to be more than 10 percent. The phenomenon of acute lung injury (ALI)/adult respiratory distress syndrome (ARDS) after infra renal abdominal aneurysm repair caused by ischemia-reperfusion is well established. The degree of disability varies from a light degree of acute respiratory failure to mortality for patients with the same profile of risk.

Primary aim is to develop a model that monitors inflammatory marker molecules collected from the bronchial epithelial lining fluid by microdialysis. The method with examination of the bronchial epithelial lining fluid by microdialysis and analysis of multiple inflammation markers as previously done by the investigators group.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: